Introduction
Tuberculosis (TB) remains a leading infectious cause of mortality and morbidity worldwide. As one-third of the world's population is estimated to be latently infected with Mycobacterium tuberculosis, people with latent tuberculosis infection (LTBI) represent a significant reservoir for future disease reactivation.
Molecular epidemiological studies have provided evidence of endogenous reactivation of M. tuberculosis after more than three decades of latent infection (Lillebaek et al., 2002) . For immunocompetent individuals, the lifetime risk of reactivation is estimated to be $10% on average; however, for persons co-infected with HIV, the risk is much higher, $10% per year (Nahid and Daley, 2006) . With the increasing rate of HIV and M. tuberculosis co-infection in many countries where TB is prevalent, development of methods for curing LTBI and preventing LTBI from reactivation remains a major challenge to global TB control. The importance of studying LTBI is particularly great in light of the recent global spread of multi-drug resistant (MDR) and extensively drug resistant (XDR) TB infection.
A proportion of the people newly infected with M. tuberculosis potentially have latent TB infection caused by MDR or XDR strains, representing both a near-and a long-term challenge to global control of TB.
The development of effective drugs for eradication of LTBI requires a better understanding of the biological basis of LTBI. Previous studies have generated two alternative hypotheses about the modes for M. tuberculosis persistence in humans. One hypothesis is that during latency, M. tuberculosis enters a very slow replicating or non-replicating dormant state in which the bacilli are insensitive to killing by the host immune system and anti-TB drugs. The other hypothesis is that during latency, M. tuberculosis replicates but is killed by the host immune system at a rate roughly equal to its replication rate. The former hypothesis was generated by studies using the Cornell mouse model (McCune et al., 1966) and its variants (Scanga et al., 1999) , and also by the Wayne in vitro stationary phase culture model of latency (Wayne, 1977) . It has been further supported by more recent studies using colony-forming unit (CFU) counting and quantitative real-time PCR to monitor the dynamics of M. tuberculosis in chronically infected mice (Munoz-Elias et al., 2005) . However, despite the widespread notion that LTBI is in a dormant static equilibrium, with very slow or no replication, other evidence has supported the alternative hypothesis of substantial continued replication in vivo (Gill et al., 2009) . Distinguishing between these different modes of Latent tuberculosis infection Genomics Molecular epidemiology
A B S T R A C T
Mycobacterium tuberculosis may survive for decades in the human body in a state termed latent tuberculosis infection (LTBI). We investigated the occurrence during LTBI of insertion/deletion events in a selected set of mononucleotide simple sequence repeats, DNA sequence changes in four M. tuberculosis genes, and large sequence variations in 4750 M. tuberculosis open reading frames. We studied 13 paired M. tuberculosis clinical isolates, with each pair representing a reactivation of LTBI more than three decades after primary infection. Absence of sequence variations between paired isolates in nearly all investigated loci suggests a low likelihood of bacterial replication during LTBI.
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M. tuberculosis persistence would provide insight into the ability of different strategies to successfully eliminate the latent bacteria, because drugs targeting actively replicating bacterial cells would have limited effect on bacterial cells in static phase. In this study, we took a novel approach that integrates molecular epidemiology with genomics to gain insight into the biological basis of human LTBI.
Materials and methods
We investigated 13 M. tuberculosis isolates from the 1960s and 13 isolates from 1990s, respectively, all sampled in Denmark. The patients in the 1990s were most likely infected during the 1960s. Subsequently, they developed TB due to reactivation of M. tuberculosis after three decades of latent infection. The transmission between these 'modern' and 'historic' cases was confirmed based on matching molecular typing patterns of their M. tuberculosis isolates and epidemiological investigation, as previously reported (Lillebaek et al., 2002 (Lillebaek et al., , 2003 . For each of the 13 reactivation cases, the estimated duration of LTBI was between 30 and 39 years investigation. The study was approved by the Health Sciences and Behavioral Sciences Institutional Review Board of the University of Michigan, the Danish National Ethical Committee, and the Danish Data Protection Agency.
To assist in understanding the effect of host immune selective pressure on latency and reactivation, we sought information about the patients' HIV status. Because HIV was not known in the 1960s, it is likely that the first set of patients were HIV sero-negative. Although TB patients were not routinely screened for HIV infection during the 1990s, HIV infection suspects were tested for HIV sero positivity, and none of the study patients from the 1990s was known to be HIV sero-positive. They had no clinical signs of immune deficiency, and their mean age at diagnosis was 62.9 years (Lillebaek et al., 2003) . Further, in Denmark, only 2% of TB patients are known to be HIV sero-positive, and HIV sero-positive TB patients are mostly younger persons from high-incidence areas in Africa or risk groups in Denmark, rather than older Danes.
Genomic DNA was extracted from Lowenstein-Jensen cultures of the study isolates using standard procedures (Murray and Thompson, 1980) . We investigated the occurrence of insertion/ deletion (indel) events in a selected set of mononucleotide simple sequence repeats (SSRs). SSRs, also known as microsatellites, are short DNA sequence stretches in which motifs of one to six bases are tandemly repeated. SSRs gain or lose repeats due to DNA replication slippage, which occurs at very high rates compared to other types of mutations (Ellegren, 2004) . Sreenu et al. (2007) reported that SSRs are distributed throughout mycobacterial genomes at an average rate of 220-230 SSR tracts per kb. Because mycobacteria lack the post-replicative DNA mismatch repair system that would normally correct for strand slippage errors during replication (Cole et al., 1998) , the occurrence of indels in their SSRs may provide insight into the question of whether or not M. tuberculosis replicates during latency.
Ten intergenic regions, likely subject to less selective pressure than coding regions, were PCR-amplified and DNA sequenced in order to detect indels among their mononucleotide SSRs (Table 1) Each standard 50 ml reaction consisted of 10 ml of 5X reaction buffer, 5 ml of GC Melt, 2 ml of each primer (at 10 mM each), 1 ml of 50Â deoxyribonucleoside triphosphate mixture, 1 ml of 50Â BD Advantage TM 2 Polymerase mixture, 2 ml (20 ng) of DNA template, and 27 ml of PCR-grade water. The same thermocycling program was used for all PCR amplifications. This program included: 94 8C (3 min), 30 cycles of 94 8C (30 s), 64 8C (30 s), and 72 8C (1 min), and a final cycle of 72 8C (10 min). The PCR products were examined by 1.0% (w/v) agarose gel electrophoresis performed in 1Â Tris-borate-EDTA buffer to determine their size. PCR products were purified for DNA sequencing using QIAquick 1 PCR Purification kit following the manufacturer's instructions (QIAGEN, Inc., Valencia, CA).
We also investigated DNA sequence changes in four M. tuberculosis genes by PCR and DNA sequencing, as described previously (Hebert et al., 2007; Talarico et al., 2007) . These four genes included genes coding for three proposed antigenic proteins, PE_PGRS26, PE_PGRS33, and PPE18, and the rpfB gene encoding a proposed resuscitation-promoting factor protein that has a role in the reactivation of LTBI (Mukamolova et al., 2002) . High numbers of genetic variants in the PE_PGRS33 and PE_PGRS26 genes have been found in the natural population of M. tuberculosis isolates; such allelic diversity among M. tuberculosis isolates indicates that these genes could serve as a source of antigenic variation for the pathogen and might have clinical and epidemiological consequences .
The genomic variability of the PPE gene family and its possible role as a major source of antigenic variation has also been welldocumented. PPE18 is a component of the new recombinant subunit tuberculosis vaccine Mtb72F. Substantial numbers of polymorphisms have been found in this gene among clinical isolates (Hebert et al., 2007) .
In addition to the SSR and genic analyses, we also considered genome-wide differences in a specific pair of isolates. One pair among the 13 pairs of isolates was chosen for a microarray-based comparative genomic hybridization to detect the differences in genomic content between the two isolates. The pair of isolates was obtained from a father and a son, in the 1960s and 1990s, respectively, representing reactivation after three decades of latency (Lillebaek et al., 2002) . The competitive hybridization of genomic DNA samples from the two isolates labeled with different fluorescence dyes was performed using a M. tuberculosis microarray (obtained from NIAID Pathogen Functional Genomics Resource Center). A total of 4750 oligonucleotide probes were on the microarray, representing 4127 open reading frames (ORFs) from the genome of M. tuberculosis strain H37Rv and 623 unique ORFs from M. tuberculosis strain CDC1551.
Results
In the SSR analysis of the 13 pairs of clinical isolates of M. tuberculosis representing the same strains before and after more than three decades of LTBI, while different pairs of isolates had different tract lengths of mononucleotide SSRs, of the 752 SSRs analyzed, there was only one SSR [(C) 9] in which an insertion was found in one of the 13 reactivation isolates, compared with its paired epidemiologically linked 'historic' isolate. No deletions were observed in the reactivation isolates.
The investigation of DNA sequence changes in the four M. tuberculosis genes produced a similar result. For 12 of the 13 pairs of isolates, we detected no DNA sequence differences in the four genes and their adjacent regions between the two isolates of the pair. However, in the same isolate that was found to have an insertion in SSR [(C) 9], a 9 bp insertion and a synonymous singlebase pair change were found in the PE_PGRS33 gene. None of the 4750 oligonucleotide probes on the microarray slide showed differential hybridization to the genomic DNA samples of the father-son isolate pair.
Discussion
In this study, we attempted to address a long-standing question about whether M. tuberculosis replicates during human LTBI. We used an innovative approach that integrates genomics with molecular epidemiological data. Our unique collection of M. tuberculosis clinical isolates, well-characterized by populationbased molecular epidemiological studies (Lillebaek et al., 2002 (Lillebaek et al., , 2003 , provided a unique opportunity for studying LTBI using a genomics approach. This study represents the first exploration of M. tuberculosis genomic content changes during human LTBI spanning three decades or more. Our results that almost no DNA sequence changes were detected during more than three decades of LTBI provide strong suggestive evidence that LTBI involves relatively little replication.
Despite the well-documented DNA polymorphisms in the PE_PGRS33, PE_PGRS26, and PPE18 genes among clinical isolates, we found no difference from the historic isolates in 12 of the 13 reactivation cases. This finding is intriguing as genes hypothesized to be involved in host-pathogen interaction are expected to be under more host selection pressure and therefore are more likely to undergo genetic changes during LTBI. The absence of DNA sequence changes in the PE_PGRS and PPE18 genes may suggest that limited bacterial replication occurred or that the pathogen has little interaction with the host immune system during LTBI, thereby supporting the hypothesis that M. tuberculosis remains truly dormant during LTBI. This possibility is further supported by our finding of relatively few changes in the 752 mononucleotide SSRs analyzed, despite the fact that mononucleotide SSRs are known to be less stable than other types of SSRs (Moxon et al., 2006) .
We note, however, that little is known about baseline mutation rates in the M. tuberculosis loci that we have investigated. Thus, due to the absence of data from serial subcultures of M. tuberculosis that would allow us to define the relationship between replication rates of M. tuberculosis and genomic sequence changes, our study cannot provide a formal quantitative argument for differentiating the predictions of the two hypotheses. Nevertheless, the view that replication is rare during LTBI is supported by the observation in a previous investigation of identical restriction fragment length polymorphism patterns for the rapidly evolving IS6110 marker between each pair among the study isolates (Lillebaek et al., 2002 (Lillebaek et al., , 2003 .
Another limitation of our study is the under-sampling of the genome of the study isolates. In each isolate pair, we investigated 14 genomic regions that included a total of 12,355 base pairs/sites at which mutation could have occurred, and considering all isolate pairs, we observed only one SSR change and a 9 bp insertion and a synonymous single-base pair change in the PE_PGRS33 gene. Because the total sample of sequences for each pair only accounted for approximately 0.3% of the total M. tuberculosis genome, it is possible that mutation patterns in this portion of the genome are not representative. A genome-wide, high-fidelity sequencing approach to uncovering genomic sequence changes during human LTBI will not only help to address our current study question about the occurrence of replication during LTBI, it will also set the stage for future work on LTBI pathogenesis and M. tuberculosis virulence factor discovery, thereby contributing to the ultimate development of new vaccines and drugs for tuberculosis control.
